Synthetic Biology Based on Genetic Logic Circuit, Using the Expression of Drug Resistance, BCRP Pump in MCF-7 Cancer Cell Line

Document Type : Research article

Authors

1 Department of Computer Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran.

2 Department of Genetics, Faculty of Basic Sciences, Shahrekord University, Shahrekord, Iran.

3 Research Institute of Biotechnology, Shahrekord University, Shahrekord, Iran.

4 Department of Computer Engineering, Faculty of Computer and Electrical Engineering, Shahid Beheshti University, Tehran, Iran.

5 Department of Medical Biotechnology, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran.

6 Institute of Research and Development, Duy Tan University, Da Nang 550000, Vietnam.

7 Mental Health Research Center, Psychosocial Health Research Institute, Iran University of Medical Sciences, Tehran, Iran.

Abstract

Biological circuits are developed as biological parts within a cell to carry out logical functions resembling those studied in electronics circuits. These circuits can be performed as a method to vary cellular functions, to develop cellular responses to environmental conditions, or to regulate cellular developments. This research explored the possibility of synthetic biology based on the genetic logic circuit A and (not B) using the inducible expression of the both BCRP drug resistance pump and its specific shRNA in MCF-7 cancer cell line utilizing the third generation of lentiviral vectors. The accuracy of the output of the proposed circuit for living cells, was confirmed by the results of the Real-Time PCR and flow cytometry at the RNA and protein levels. At the RNA level, the effect of the inducers on the BCRP gene expression and silencing were investigated by real-time PCR. Furthermore, at the protein level, induction of the expression of the BCRP pump resulted in driving out of the substrate from inside the cells leading to the decrease of the fluorescent emission from the transfected cells. We successfully designed and implemented the genetic logic circuit A and (not B) using the inducible expression of the both BCRP drug resistance pump and its specific shRNA in MCF-7 cancer cells.

Graphical Abstract

Synthetic Biology Based on Genetic Logic Circuit, Using the Expression of Drug Resistance, BCRP Pump in MCF-7 Cancer Cell Line

Keywords


  • Martin VJJ, Pitera DJ, Withers ST, Newman JD and Keaslin JD. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat. Biotechnol. (2003) 21: 796-802.
  • De Jong, Hidde. Modeling and simulation of genetic regulatory systems: a literature review. Journal of computational biology 9.1 (2002): 67-103.
  • Martin, Vincent JJ, et al. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nature biotechnology 21.7 (2003): 796.
  • Ro, Dae-Kyun, et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440.7086 (2006): 940.
  • Reza, F., et al. Engineering novel synthetic biological systems. IET Synthetic Biology 1.1 (2007): 48-52.
  • Ying, Z., C. Zhou, and O. Oglesby. Large-scale drug function prediction by integrating qid d2 in biospice. Computational Systems Bioinformatics Conference. 2002.
  • Rubin, Edward M. Genomics of cellulosic biofuels. Nature 454.7206 (2008): 841..
  • Atsumi, Shota, and James C. Liao. Metabolic engineering for advanced biofuels production from Escherichia coli. Current opinion in biotechnology 19.5 (2008): 414-419.
  • Ferry, Michael S., Jeff Hasty, and Natalie A. Cookson. Synthetic biology approaches to biofuel production. (2012): 9-12.
  • Kemmer, Christian, et al. A designer network coordinating bovine artificial insemination by ovulation-triggered release of implanted sperms. Journal of controlled release 150.1 (2011): 23-29.
  • Xie, Zhen, et al. Multi-input RNAi-based logic circuit for identification of specific cancer cells. Science 333.6047 (2011): 1307-1311.
  • Weber, Wilfried, et al. A synthetic mammalian gene circuit reveals antituberculosis compounds. Proceedings of the National Academy of Sciences 105.29 (2008): 9994-9998
  • Saeidi, Nazanin, et al. Engineering microbes to sense and eradicate Pseudomonas aeruginosa, a human pathogen. Molecular systems biology 7.1 (2011): 521.
  • Lo, Tat-Ming, et al. Designing a synthetic genetic circuit that enables cell density-dependent auto-regulatory lysis for macromolecule release. Chemical Engineering Science 103 (2013): 29-35.
  • Howard, Thomas P., et al. Synthesis of customized petroleum-replica fuel molecules by targeted modification of free fatty acid pools in Escherichia coli. Proceedings of the National Academy of Sciences 110.19 (2013): 7636-7641.
  • Khalil, Ahmad S., and James J. Collins. Synthetic biology: applications come of age. Nature Reviews Genetics 11.5 (2010): 367.
  • Myers, Chris J. Engineering genetic circuits. Chapman and Hall/CRC, 2016.
  • Regot, Sergi, et al. Distributed biological computation with multicellular engineered networks. Nature 469.7329 (2011): 207.
  • Tamsir, Alvin, Jeffrey J. Tabor, and Christopher A. Voigt. Robust multicellular computing using genetically encoded NOR gates and chemical ‘wires’. Nature 469.7329 (2011): 212.
  • Friedland, Ari E., et al. Synthetic gene networks that count. science 324.5931 (2009): 1199-1202.
  • Leisner, Madeleine, et al. Rationally designed logic integration of regulatory signals in mammalian cells. Nature nanotechnology 5.9 (2010): 666.
  • Canton, Barry, Anna Labno, and Drew Endy. Refinement and standardization of synthetic biological parts and devices. Nature biotechnology 26.7 (2008): 787.
  • Gottesman, Michael M., and Ira Pastan. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annual review of biochemistry 62.1 (1993): 385-427.
  • Zheng, Hua-Chuan. The molecular mechanisms of chemoresistance in cancers. Oncotarget 8.35 (2017): 59950
  • Yu, Yang, Michelle Montag Lowy, and Randolph C. Elble. Tet-On lentiviral transductants lose inducibility when silenced for extended intervals in mammary epithelial cells. Metabolic engineering communications 3 (2016): 64-67.
  • Shearer, Robert F., and Darren N. Saunders. Experimental design for stable genetic manipulation in mammalian cell lines: lentivirus and alternatives. Genes to Cells 20.1 (2015): 1-10.
  • Rao, Donald D., et al. siRNA vs. shRNA: similarities and differences. Advanced drug delivery reviews 61.9 (2009): 746-759.
  • Elahian, Fatemeh, Fatemeh Kalalinia, and Javad Behravan. Dexamethasone downregulates BCRP mRNA and protein expression in breast cancer cell lines. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 18.1 (2009): 9-15.
  • Elahian, Fatemeh, Fatemeh Kalalinia, and Javad Behravan. Evaluation of indomethacin and dexamethasone effects on BCRP-mediated drug resistance in MCF-7 parental and resistant cell lines. Drug and chemical toxicology 33.2 (2010): 113-119.
  • Frezza, Brian M., Scott L. Cockroft, and M. Reza Ghadiri. Modular multi-level circuits from immobilized DNA-based logic gates. Journal of the American Chemical Society 129.48 (2007): 14875-14879.
  • Rinaudo, Keller, et al. A universal RNAi-based logic evaluator that operates in mammalian cells. Nature biotechnology 25.7 (2007): 795.
  • Culler, Stephanie J., Kevin G. Hoff, and Christina D. Smolke. Reprogramming cellular behavior with RNA controllers responsive to endogenous proteins. Science 330.6008 (2010): 1251-1255
  • Pasotti, Lorenzo, et al. Multiplexing and demultiplexing logic functions for computing signal processing tasks in synthetic biology. Biotechnology Journal 6.7 (2011): 784-795.
  • Ausländer, Simon, et al. Programmable single-cell mammalian biocomputers. Nature 487.7405 (2012): 123.